MAXCYTE, INC. Quarterly Operating Margin in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Maxcyte, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2024.
  • Maxcyte, Inc. Operating Margin for the quarter ending September 30, 2024 was -102 %, a 17.6% increase year-over-year.
  • Maxcyte, Inc. annual Operating Margin for 2023 was -117 %, a 89.2% decline from 2022.
  • Maxcyte, Inc. annual Operating Margin for 2022 was -61.8 %, a 15.2% decline from 2021.
  • Maxcyte, Inc. annual Operating Margin for 2021 was -53.7 %, a 27% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -102 +21.7 +17.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -102 -1.8 -1.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -108 -19.4 -22% Jan 1, 2024 Mar 31, 2024
Q4 2023 -117 -55.2 -89.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -123 -62.5 -103% Jul 1, 2023 Sep 30, 2023
Q2 2023 -100 -51.2 -105% Apr 1, 2023 Jun 30, 2023
Q1 2023 -88.2 -47.2 -115% Jan 1, 2023 Mar 31, 2023
Q4 2022 -61.8 -8.15 -15.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -60.9 Jul 1, 2022 Sep 30, 2022
Q2 2022 -48.9 Apr 1, 2022 Jun 30, 2022
Q1 2022 -41 Jan 1, 2022 Mar 31, 2022
Q4 2021 -53.7 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.